Status:
COMPLETED
Chiropractic T Cell Study
Lead Sponsor:
University of British Columbia
Conditions:
Intervention
Waitlist Control
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Some studies suggest that specific chiropractic care (techniques known as "spinal manipulation therapy") can have benefits to the immune system but studies are scarce, sample sizes small, and methodol...
Eligibility Criteria
Inclusion
- Must be between the ages of 18-70.
- Must exhibit vertebral subluxation as measured by a misalignment between one or more vertebrae in relation to normal spinal alignment.
- Have not been sick for the past 3 weeks (immune function).
- Non-smoker.
- Must be able to fast for 10-12 hours.
Exclusion
- To have had a chiropractic intervention within the past 6 months.
- To have a condition that may limit the ability to apply a high velocity, low amplitude (HVLA) thrust to the spine such as but not limited to ligament damage, reduced bone density, or other factors that weaken the body's ability to withstand reasonable care (bone cancer, fractures, osteoporosis, etc.)
- To have excessive scoliotic curvature of the spine (\> 30º) as measured by identifying the first vertebrae, and the most laterally displaced vertebrae that exhibits tilt below it.
Key Trial Info
Start Date :
July 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05412602
Start Date
July 25 2022
End Date
December 31 2023
Last Update
February 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia Okanagan
Kelowna, British Columbia, Canada, V1V 1V7